ClinicalTrials.gov
ClinicalTrials.gov Menu

Tianjin Gestational Diabetes Prevention Program (TGDPP) (GDM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01554358
Recruitment Status : Unknown
Verified November 2015 by HunKun Liu, Tianjin Women and Children's Health Center.
Recruitment status was:  Recruiting
First Posted : March 14, 2012
Last Update Posted : November 4, 2015
Sponsor:
Information provided by (Responsible Party):
HunKun Liu, Tianjin Women and Children's Health Center

Brief Summary:
A total of 1,180 women diagnosed with Gestational Diabetes Mellitus (GDM) from 2005 to 2009 have and continues to be randomly assigned to either the intervention group or the control group. GDM women in the intervention group will have five consulting sessions with a dietician during the first year and two sessions during the second year. The intervention group are given detailed advice about how to achieve the six goals of the intervention. The primary aim will test whether lifestyle intervention can reduce incident Type 2 Diabetes (T2D) in women with prior GDM. The second aim will test gene-intervention interactions through fine-mapping established genes for glucose, IR, lipids, obesity and T2D in relation to metabolic traits for T2D in GDM women.

Condition or disease Intervention/treatment Phase
Gestational Diabetes Mellitus (GDM) Behavioral: Lifestyle intervention Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 1180 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Prevention
Official Title: Lifestyle and Genetic Factors on Diabetes Risk in Women With GDM After Delivery: Tianjin Gestational Diabetes Prevention Program (TGDPP)
Study Start Date : August 2009
Actual Primary Completion Date : July 2011

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Lifestyle counseling
The women in the intervention group will be given detailed advice about how to achieve the six evidence-based goals of the intervention,7-9 including: 1) reduction in 5-10% of initial body weight in women with body mass index (BMI) ≥24 kg/m2 through the reduction of at least 10% of total calories of their normal meals, 2) total fat intake <30% of energy consumed, 3) saturated fat intake <10% of energy consumed, 4) carbohydrate intake 55-65% of energy consumed, 5) fiber intake 20-30g per day, and 6) moderate or vigorous exercise for at least 30 min daily, seven days each week.
Behavioral: Lifestyle intervention

The women in the intervention group will be given detailed advice about how to achieve the six evidence-based goals of the intervention,7-9 including: 1) reduction in 5-10% of initial body weight in women with body mass index (BMI) ≥24 kg/m2 through the reduction of at least 10% of total calories of their normal meals, 2) total fat intake <30% of energy consumed, 3) saturated fat intake <10% of energy consumed, 4) carbohydrate intake 55-65% of energy consumed, 5) fiber intake 20-30g per day, and 6) moderate or vigorous exercise for at least 30 min daily, seven days each week.

No Intervention: Control
the subjects in the control group had been educated regarding general principles of healthy lifestyle that benefits T2D and obesity prevention, and also informed about the current evidence showing that the lifestyle intervention is effective in women at high risk for T2D during the "run-in" period.



Primary Outcome Measures :
  1. incident type 2 diabetes [ Time Frame: during 2-year follow-up ]

Secondary Outcome Measures :
  1. approximately 40 SNPs [ Time Frame: during 2-year follow-up ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 49 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Age 20-49 years
  2. Women diagnosed with GDM between 2005 and 2009.

Exclusion Criteria:

  1. Age < 20 and ≥ 50 years
  2. Newly diagnosed diabetes in the screening visit
  3. The presence of any chronic diseases that could seriously reduce their life expectancy or their ability to participate in the trial
  4. Unable or unwilling to give informed consent or communicate with study staff
  5. Currently pregnant, or planning to become pregnant in the next four years

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01554358


Contacts
Contact: Huikun Liu, PhD 86 2258297935 huikun_liu@sina.com

Locations
China
Tianjin Women's and Children's Health Center Recruiting
Tianjin, China, 30070
Contact: Huikun Liu, PhD       huikun_liu@sina.com   
Principal Investigator: Huiguang Tian, PhD         
Principal Investigator: Gang Hu, PhD         
Sponsors and Collaborators
Tianjin Women and Children's Health Center

Responsible Party: HunKun Liu, Project co-investigator, Tianjin Women and Children's Health Center
ClinicalTrials.gov Identifier: NCT01554358     History of Changes
Other Study ID Numbers: TWCHC09-01
First Posted: March 14, 2012    Key Record Dates
Last Update Posted: November 4, 2015
Last Verified: November 2015

Keywords provided by HunKun Liu, Tianjin Women and Children's Health Center:
Gestational diabetes mellitus
Lifestyle intervention

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes, Gestational
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Pregnancy Complications